Pharmacokinetics and Dosimetry Studies for Optimization of Pretargeted Radioimmunotherapy in CEA-Expressing Advanced Lung Cancer Patients
about
Immuno-PET for Clinical Theranostic Approaches.New insights into the pretargeting approach to image and treat tumours.Recent advances of bispecific antibodies in solid tumors.Improving theranostics in pancreatic cancer.Theranostic pretargeted radioimmunotherapy of internalizing solid tumor antigens in human tumor xenografts in mice: Curative treatment of HER2-positive breast carcinoma
P2860
Pharmacokinetics and Dosimetry Studies for Optimization of Pretargeted Radioimmunotherapy in CEA-Expressing Advanced Lung Cancer Patients
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Pharmacokinetics and Dosimetry ...... Advanced Lung Cancer Patients
@ast
Pharmacokinetics and Dosimetry ...... Advanced Lung Cancer Patients
@en
type
label
Pharmacokinetics and Dosimetry ...... Advanced Lung Cancer Patients
@ast
Pharmacokinetics and Dosimetry ...... Advanced Lung Cancer Patients
@en
prefLabel
Pharmacokinetics and Dosimetry ...... Advanced Lung Cancer Patients
@ast
Pharmacokinetics and Dosimetry ...... Advanced Lung Cancer Patients
@en
P2093
P2860
P50
P356
P1476
Pharmacokinetics and Dosimetry ...... Advanced Lung Cancer Patients
@en
P2093
Aurore Rauscher
Caroline Rousseau
Damien Masson
David M Goldenberg
Evelyne Cerato
Jacques Barbet
José Hureaux
Latifa Rbah-Vidal
Ludovic Ferrer
Olivier Couturier
P2860
P356
10.3389/FMED.2015.00084
P577
2015-11-27T00:00:00Z